'Pneumococcal disease' presentation slideshows

724 views • 58 slides

Schedule Changes 2011

889 views • 55 slides

Streptococcus pneumina

Streptococcus pneumina

1.85k views • 52 slides

Vaccines for Streptococcus pneumoniae

738 views • 48 slides

Streptococcus pneumoniae pneumococcus

Streptococcus pneumoniae pneumococcus. Dr.T.V.Rao MD. Scientific Classification Kingdom: Bacteria / Phylum: Firmicutes / Class: Diplococci / Order: Lactobacillales / Family: Streptococcaceae / Genus: Streptococcus. Binomial name: Streptococcus pneumoniae

1.81k views • 47 slides

Flu and Pneumo (Vaxigrip and Pneumo23)

Flu and Pneumo (Vaxigrip and Pneumo23). Dennis S. Quiambao, MD Medical and Government Affairs Manager. Influenza. Influenza. "An unvarying disease caused by a varying virus". Kilbourne, 1980. Influenza. Worldwide: 10% of the population gets the flu

864 views • 34 slides

Influenza and Pneumonia and Foodborne Illness

Influenza and Pneumonia and Foodborne Illness. Megan Davies, MD State Epidemiologist Division of Public Health NCDHHS. Pneumonia: The Big Picture. Leading cause of death globally Major public health problem in the US >55,000 deaths (2006) 1.2 million hospitalizations (2006)

478 views • 34 slides

Preventie INVASIEVE PNEUMOKOKKENZIEKTE BIJ VOLWASSENEN VAN 50 JAAR EN OUDER

Prevenar 13. Preventie INVASIEVE PNEUMOKOKKENZIEKTE BIJ VOLWASSENEN VAN 50 JAAR EN OUDER. Christophe Libeer Pneumoloog AZ Sint-Maarten Mechelen. Overzicht presentatie. Pneumokokken-ziekte. Conjugate technology. Conjugaat technologie. Ervaring met Prevenar. Prevenar 13.

519 views • 32 slides

Infectious Diseases (Communicable diseases)

Infectious Diseases (Communicable diseases). Start with an activity. What does infectious mean? How many infectious diseases in children can you list? How are they transmitted (passed on)? Are the diseases you have named preventable through vaccination?.

1.56k views • 32 slides

Pneumococcal Disease and Pneumococcal Vaccines

Pneumococcal Disease and Pneumococcal Vaccines. Epidemiology and Prevention of Vaccine-Preventable Diseases National Immunization Program Centers for Disease Control and Prevention. Revised March 2002. Pneumococcal Disease. S. pneumoniae first isolated by Pasteur in 1881

631 views • 31 slides

Diphtheria (tonsillar)

Diphtheria (tonsillar). Diphtheria (bull neck). Tetanus (child). Tetanus (neonatal). Tetanus (baby). Tetanus (adult). Pertussis (child). Polio (Drinker respirator ward). Polio (girl). Polio (adult). Measles . Measles. Measles (prominent conjunctivitis). Measles.

519 views • 28 slides

Global Issues in Comparing Vaccination Strategies

Global Issues in Comparing Vaccination Strategies . Dr Lara Wolfson Vaccine Assessment & Monitoring Department of Immunization, Vaccines & Biologicals. Vaccination Strategies: WHO. Overview of work at WHO Examples of current work Unmet needs.

461 views • 27 slides

Evaluating Vaccine Effectiveness Using Serologic Assays

Evaluating Vaccine Effectiveness Using Serologic Assays. Cara R. Fiore, Ph D Office of Vaccines Research and Review Center for Biologics Evaluation and Review U. S. Food and Drug Administration Vaccines Europe, Brussels December 2011. Objectives. Background:

614 views • 27 slides

Changing the Paradigm: Vaccination as a Key Prevention Step in Daily Practice

Changing the Paradigm: Vaccination as a Key Prevention Step in Daily Practice. Moderator Charles Feldman, MB BCh, DSc, PhD Professor of Pulmonology and Chief Physician Charlotte Maxeke Johannesburg Academic Hospital University of the Witwatersrand Johannesburg, South Africa. Panelists

357 views • 23 slides

National Vaccine Advisory Committee March 25, 2019 Jeffery Talbert, PhD Patricia R. Freeman, PhD

Assessing Disparities in Pneumococcal Vaccine Service Delivery in the Rural Fee-for-Service Medicare Population. National Vaccine Advisory Committee March 25, 2019 Jeffery Talbert, PhD Patricia R. Freeman, PhD Pharmacy Practice and Science University of Kentucky College of Pharmacy.

402 views • 20 slides

Implementing Pneumococcal Vaccination in the Elderly and High-Risk Adults

Implementing Pneumococcal Vaccination in the Elderly and High-Risk Adults. Donald B. Middleton, MD Professor of Family Medicine University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania Litjen (L.J) Tan, MS, PhD Chief Strategy Officer Immunization Action Coalition

405 views • 17 slides

Is vaccination a valuable preventive strategy?

Cost-effectiveness of pneumococcal vaccination for older people: a study in five western European countries. Ament A, Baltussen R, Duru G, Rigaud-Bully C, De Graeve D, et al , Journal of infectious diseases, Clinical Infectious Diseases, vol 31, nr 2, pp 444-50.

268 views • 15 slides

IMMUNISATION

282 views • 14 slides

Program Support Update

Program Support Update. NHMRC Pneumovax23 Recommendations. Reference: 1. The Australian Immunisation Handbook, NHMRC. 9 th Edition, 2008, Chapter 3.15. History of the National Pneumococcal Vaccination Program for Older Australians ( > 65 years).

169 views • 6 slides

ABSTRACT

97 views • 1 slides